|
Volumn 102, Issue 22, 2005, Pages 7781-7782
|
Molecular engineering human hepatocytes into pancreatic beta cells for diabetes therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOVIRUS VECTOR;
IMMUNOSUPPRESSIVE AGENT;
INSULIN;
TRANSCRIPTION FACTOR PDX 1;
AUTOIMMUNITY;
BIOENGINEERING;
CADAVER DONOR;
CELL DIFFERENTIATION;
CELL TRANSPLANTATION;
ELECTRONICS;
GENE THERAPY;
GENETIC TRANSDUCTION;
GRAFT REJECTION;
HUMAN;
HYPOGLYCEMIA;
IMMUNOSURVEILLANCE;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN PUMP;
INSULIN RELEASE;
INSULIN TREATMENT;
LIVER CELL;
NONHUMAN;
NOTE;
PANCREAS ISLET BETA CELL;
PANCREAS TRANSPLANTATION;
PRIORITY JOURNAL;
SIDE EFFECT;
STEM CELL;
CELL DIFFERENTIATION;
DIABETES MELLITUS, TYPE 1;
GENE THERAPY;
GENETIC ENGINEERING;
HEPATOCYTES;
HOMEODOMAIN PROTEINS;
HUMANS;
ISLETS OF LANGERHANS;
TRANS-ACTIVATORS;
TRANSDUCTION, GENETIC;
ADENOVIRIDAE;
|
EID: 20344386987
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.0503261102 Document Type: Note |
Times cited : (8)
|
References (9)
|